Three-dimensional Ultrasound Applying in Assessment of Intrauterine Adhesions
NCT ID: NCT04930913
Last Updated: 2021-06-18
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
600 participants
OBSERVATIONAL
2020-07-01
2023-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Treatment of Intrauterine Adhesions and Its Distribution of Genital Tract Flora
NCT03731689
Sonohysterography , 3D Ultrasonography and Hysteroscopy in Assessment of Uterine Factor in Cases of Female Infertility
NCT02399501
Validation and Optimisation of Ultrasound Diagnosis of Adenomyosis
NCT06795711
Feasibility of Four-dimensional Hysterosalpingo-contrast Sonography With SonoVue for Assessment of Tubal Patency
NCT02505555
Detection of the Uterine Abnormalities Missed in an Ultrasound Scan and/or Hysterosalpingography Using Hysteroscopy, in Females Presenting With Unexplained Infertility
NCT04179253
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
2. Study population 600 patients from three tertiary hospitals suspected of having IUA will be prospectively recruited. Thorough assessment including previous reproductive and surgical history as well as menstrual pattern will be performed.
3. Study Procedure 3.1 Diagnosis
IUA will be diagnosed in coronal plane, based on a suggestion reported by a Taiwanese study. The morphological characteristics of the endometrium suggesting IUA include as follow:
* marginal irregularity (in coronal plane)
* defects (interrupted endometrial line)
* obliteration (undetectable endometrium suggesting extensive adhesion)
* fibrosis or calcification (hyperechoic lesion without posterior shadowing, or with posterior shadowing) 3.2 Ultrasound
* Transvaginal Ultrasound will be performed in luteal phase.
* Using E10 Voluson GE with 3D/4D TV probe.
* Scan and rendering will be performed in a standardized technique (omniview mode).
* Several parameters will be measured including endometrial volume, uterine volume, vascularization (VI FI VFI).
3.3 Hysteroscopy
* Hysteroscopic exam will be used as the gold standard for the diagnosis of intrauterine adhesions.
* hysteroscopy will confirm the presence, extent, and morphological characteristics of adhesions and the quality of the endometrium.
3.4 Surgical technique
* Hysteroscopic surgery will be performed in a standardized manner.
* The severity and extent of intrauterine adhesions will be scored according to different classification systems. (ESGE/AFS/China consensus)
* a Foley-catheter filled with 3.0ml normal saline will be inserted into the uterus for 5-7 days after surgery.
3.5 Postoperative treatments
* All subjects will be treated with Hormone therapy for at least 8 weeks
* A second-look hysteroscopy will be carried out 4 weeks after surgery, a third-look hysteroscopy will be carried out 12 weeks after surgery
* A second-look 3D US will be carried out in luteal phase after two menstrual peroid postoperatively.
3.6 Follow up
* Follow-up styles: the doctor's outpatient review, telephone, WeChat and so on.
* Follow-up time:3 months, 6months, 12 months after the operation.
* Follow up the results of hysteroscopy and 3D US at 3 months after the operation and the menstrual improvement at 6months after the operation and pregnancy outcomes at 12 months after the operation
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
OTHER
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Three-dimensional Ultrasound
women suspected of having adhesions will perform 3D US
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* oligomenorrhea or amenorrhea
* BMI 18-30
* regular menstruation
* written consent obtained
Exclusion Criteria
* Patients with uterine fibroids, adenomyosis, uterine malformation and endometrial polyps
* Patients with uterine artery embolization
* History of endometrial hyperplasia
* Irregular menstruation
* Patients with severe complications
* Patients with hypoovarian function
20 Years
40 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Fu Xing Hospital, Capital Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Xiaowu Huang
Director of department
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Li Tinchiu
Role: STUDY_CHAIR
Fuxing Hospital,Capital Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Fu Xing Hospital, Capital Medical University
Beijing, , China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
References
Explore related publications, articles, or registry entries linked to this study.
Kim MJ, Lee Y, Lee C, Chun S, Kim A, Kim HY, Lee JY. Accuracy of three dimensional ultrasound and treatment outcomes of intrauterine adhesion in infertile women. Taiwan J Obstet Gynecol. 2015 Dec;54(6):737-41. doi: 10.1016/j.tjog.2015.10.011.
Amin TN, Saridogan E, Jurkovic D. Ultrasound and intrauterine adhesions: a novel structured approach to diagnosis and management. Ultrasound Obstet Gynecol. 2015 Aug;46(2):131-9. doi: 10.1002/uog.14927. Epub 2015 Jul 20. No abstract available.
Carrascosa P, Capunay C, Vallejos J, Carpio J, Baronio M, Papier S. Two-dimensional and three-dimensional imaging of uterus and fallopian tubes in female infertility. Fertil Steril. 2016 Jun;105(6):1403-1420.e7. doi: 10.1016/j.fertnstert.2016.04.016. Epub 2016 Apr 29.
AAGL Elevating Gynecologic Surgery. AAGL practice report: practice guidelines on intrauterine adhesions developed in collaboration with the European Society of Gynaecological Endoscopy (ESGE). Gynecol Surg. 2017;14(1):6. doi: 10.1186/s10397-017-1007-3. Epub 2017 May 1. No abstract available.
Salazar CA, Isaacson K, Morris S. A comprehensive review of Asherman's syndrome: causes, symptoms and treatment options. Curr Opin Obstet Gynecol. 2017 Aug;29(4):249-256. doi: 10.1097/GCO.0000000000000378.
Dreisler E, Kjer JJ. Asherman's syndrome: current perspectives on diagnosis and management. Int J Womens Health. 2019 Mar 20;11:191-198. doi: 10.2147/IJWH.S165474. eCollection 2019.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2020-1-7027
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.